A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsy

The primary objective of this study is to evaluate the efficacy of the 3 selected dose regimens of Padsevonil (PSL) administered concomitantly with up to 3 AEDs compared with placebo for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy. The secondary objective is to assess the safety and tolerability of all doses of PSL in relation to placebo.

Principal Investigator(s)
Mohamad Z. Koubeissi, MD
Contact Phone Number
Request Information

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

3 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.